ArticleCureus2026
Knowledge, Attitudes, and Practices Regarding Herpes Zoster and Its Vaccine Among Primary Health Care Attendees in the United Arab Emirates: A Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Herpes zoster (HZ) is a reactivation of the latent varicella-zoster virus, with incidence increasing in older adults. Despite the availability of an effective vaccine, uptake remains low globally and in the United Arab Emirates (UAE). Objectives The objective of the study was to assess knowledge, attitudes, and practices (KAP) regarding HZ and its vaccine among primary health care (PHC) attendees in the UAE, and to identify demographic factors associated with knowledge levels. Methods A cross-sectional study was conducted from March to May 2025 in primary health care (PHC) centers within Emirates Health Services (EHS) across six emirates of the United Arab Emirates. Adults aged ≥18 years were recruited using convenience sampling. Data were collected via a validated, adapted questionnaire covering sociodemographic characteristics and knowledge, attitudes, and practices regarding HZ and its vaccine. Associations were analyzed using chi-square tests. Results Of 389 participants, 268 (68.9%) were female, and 265 (68.1%) were aged 18-49 years. Knowledge levels were high in 67 (17.2%), moderate in 197 (50.6%), and low in 125 (32.1%) participants. Higher knowledge was significantly associated with female gender, younger age, higher education, health insurance, and prior chickenpox history (all p<0.05). Most respondents, 294 (76.0%), were interested in learning about HZ, 317 (81.5%) were interested in prevention strategies, and 287 (73.7%) reported willingness to vaccinate if recommended by a physician. Vaccine cost was reported as likely or extremely likely to influence decision-making by 140 (35.9%) participants. Overall, 6.4% (n = 25) of participants reported having already received the herpes zoster vaccine. The most common reasons for hesitancy included fear of side effects (77; 19.8%) and low perceived risk (34; 8.7%). Conclusion Knowledge of herpes zoster among PHC attendees was moderate, while attitudes toward vaccination were generally favorable, particularly when supported by a physician's recommendation. Targeted educational interventions, strengthened physician engagement, and addressing cost concerns may help improve vaccine uptake in the UAE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.